506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
type: MedicalStudy
description: Phase II-Study With Nelarabine in Patients With Refractory Oder Relapsed T- ALL or T-lymphoblastic Lymphoma (Amend.7)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2003-06
end date: 2008-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00684619
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Goethe University
study subject: T-ALL, T-NHL (Lymphoblastic)
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: T-ALL, T-NHL (Lymphoblastic)

AI Analytics
type: Organization